Clinical Trials in Burjassot, Spain
Locations / Burjassot, Spain
Delta Trials records 27 clinical trials conducted in Burjassot, Spain, making it a notable site of clinical research activity. These trials across 22 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Burjassot has changed over time.
27
Total Trials
22
Conditions
2
Terminated since 2020
Browse by condition (22 total)
- All Neovascular age-related macular degeneration trials
- Diabetic macular edema 4 trialsAll Diabetic macular edema trials
- Geographic atrophy 3 trialsAll Geographic atrophy trials
- Macular degeneration 2 trialsAll Macular degeneration trials
- Dermatitis, atopic 2 trialsAll Dermatitis, atopic trials
- Hypertension 2 trialsAll Hypertension trials
- Age-related macular degeneration 2 trialsAll Age-related macular degeneration trials
- COVID-19 1 trialAll COVID-19 trials
- COPD 1 trialAll COPD trials
- All Age-related macular degeneration (amd) trials
- Macular edema 1 trialAll Macular edema trials
- High risk cardiovascular disease 1 trialAll High risk cardiovascular disease trials
- Diabetic macular edema (dme) 1 trialAll Diabetic macular edema (dme) trials
- High cardiovascular risk 1 trialAll High cardiovascular risk trials
- Geographic atrophy (ga) 1 trialAll Geographic atrophy (ga) trials
- Diabetes mellitus, type 2 1 trialAll Diabetes mellitus, type 2 trials
- Vaccines, pneumococcal 1 trialAll Vaccines, pneumococcal trials
- Ventilator associated pneumonia 1 trialAll Ventilator associated pneumonia trials
- Branch retinal vein occlusion 1 trialAll Branch retinal vein occlusion trials
- All Chronic cutaneous lupus erythematosus trials